Integrated Filing — IndAS

General information about company
Scrip Code	524212
NSE Symbol	WANBURY
MSEI Symbol	NOTLISTED
ISIN	INE107F01022
Name of company	WANBURY LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	15-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	08-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	PHARMACEUTICALS
Start date and time of board meeting	15-May-2025   17:30:00
End date and time of board meeting	15-May-2025   20:30:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2024-05-16
Indicate Company website link for updated RPT policy of the Company	www.wanbury.comhttps://ess.wanbury.com/wanbury/www/investorrelsl/policies/Related%20Party%20Transactions%20Policy.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
Not Applicable

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	1719995000	5995142000
	Other income	18443000	34933000
	Total income	1738438000	6030075000
2	Expenses
(a)	Cost of materials consumed	759454000	2778820000
(b)	Purchases of stock-in-trade	38935000	150759000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	44811000	15114000
(d)	Employee benefit expense	264214000	1042376000
(e)	Finance costs	90424000	369507000
(f)	Depreciation, depletion and amortisation expense	33742000	133111000
(f)	Other Expenses
1	OTHER EXPENSES	316317000	1244881000
	Total other expenses	316317000	1244881000
	Total expenses	1547897000	5734568000
3	Total profit before exceptional items and tax	190541000	295507000
4	Exceptional items	0	0
5	Total profit before tax	190541000	295507000
6	Tax expense
7	Current tax	58609000	58609000
8	Deferred tax	-70633000	-68403000
9	Total tax expenses	-12024000	-9794000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	202565000	305301000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	202565000	305301000
17	Other comprehensive income net of taxes	466000	-3685000
18	Total Comprehensive Income for the period	203031000	301616000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	327705000	327705000
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve		265013000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	6.18	9.32
	Diluted earnings (loss) per share from continuing operations	5.98	8.98
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	6.18	9.32
	Diluted earnings (loss) per share from continuing and discontinued operations	5.98	8.98
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	1896911000
	Capital work-in-progress	53815000
	Investment property	0
	Goodwill	106849000
	Other intangible assets	2282000
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	203000
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	40365000
	Total non-current financial assets	40568000
	Deferred tax assets (net)	70382000
	Other non-current assets	33933000
	Total non-current assets	2204740000
2	Current assets
	Inventories	376797000
	Current financial asset
	Current investments	1311000
	Trade receivables, current	1141563000
	Cash and cash equivalents	40605000
	Bank balance other than cash and cash equivalents	87682000
	Loans, current	0
	Other current financial assets	21028000
	Total current financial assets	1292189000
	Current tax assets (net)	0
	Other current assets	265446000
	Total current assets	1934432000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	4139172000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	327705000
	Other equity	265013000
	Total equity attributable to owners of parent	592718000
	Non controlling interest
	Total equity	592718000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	1602926000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	14700000
	Total non-current financial liabilities	1617626000
	Provisions, non-current	174518000
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	8190000
	Total non-current liabilities	1800334000
	Current liabilities
	Current financial liabilities
	Borrowings, current	129357000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	39846000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	1344802000
	Total Trade payable	1384648000
	Other current financial liabilities	60833000
	Total current financial liabilities	1574838000
	Other current liabilities	145723000
	Provisions, current	25559000
	Current tax liabilities (Net)	0
	Deferred government grants, Current	0
	Total current liabilities	1746120000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	3546454000
	Total equity and liabilites	4139172000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Acturial Gain/Loss on defined benefit obligation	897000	-5484000
	Total Amount of items that will not be reclassified to profit and loss	897000	-5484000
2	Income tax relating to items that will not be reclassified to profit or loss	314000	-1916000
3	Amount of items that will be reclassified to profit and loss
1	Effective portion of gain and losses on hedging instruments in a cash flow hedge	-180000	-180000
	Total Amount of items that will be reclassified to profit and loss	-180000	-180000
4	Income tax relating to items that will be reclassified to profit or loss	-63000	-63000
5	Total Other comprehensive income	466000	-3685000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			295507000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			369507000
	Adjustments for decrease (increase) in inventories			-16565000
	Adjustments for decrease (increase) in trade receivables, current			-253776000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			4611000
	Adjustments for decrease (increase) in other non-current assets			-10130000
	Adjustments for other financial assets, non-current			-989000
	Adjustments for other financial assets, current			-11444000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			-220979000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			-5724000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			133111000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			4845000
	Adjustments for provisions, non-current			13894000
	Adjustments for other financial liabilities, current			1348000
	Adjustments for other financial liabilities, non-current			-15650000
	Adjustments for unrealised foreign exchange losses gains			-2375000
	Adjustments for dividend income			0
	Adjustments for interest income			0
	Adjustments for share-based payments			11440000
	Adjustments for fair value losses (gains)			-1079000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-19621000
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			0
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			-19576000
	Net cash flows from (used in) operations			275931000
	Dividends received			0
	Interest paid			7139000
	Interest received			0
	Income taxes paid (refund)			3704000
	Other inflows (outflows) of cash			-4072000
	Net cash flows from (used in) operating activities			261016000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			3965000
	Purchase of property, plant and equipment			490275000
	Proceeds from sales of investment property			2365000
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			6330000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-34129000
	Net cash flows from (used in) investing activities	-511744000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			250000
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			638240000
	Repayments of borrowings			0
	Payments of lease liabilities			33743000
	Dividends paid			0
	Interest paid			347415000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			257332000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			6604000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			6604000
	Cash and cash equivalents cash flow statement at beginning of period			34001000
	Cash and cash equivalents cash flow statement at end of period			40605000